Feng Zhang
Impact in
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Genetics top 0.1%
- Genomic variations and chromosomal abnormalities
Papers in
- Cancer Research 111
- Cancer-related molecular mechanisms research 52
- MicroRNA in disease regulation 33
- Hepatology 51
- Liver physiology and pathology 30
- Co-authors
- James R. LupskiWenli GuShizhong ZhengMatthew E. HurlesZili ZhangJiangjuan ShaoJin LiClaudia M.B. Carvalho
- Journals
- PLoS ONE (14 papers)Human Molecular Genetics (13 papers)The American Journal of Human Genetics (9 papers)Annals of Plastic Surgery (9 papers)Frontiers in Oncology (8 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Feng Zhang
703 papers receiving 19.8k citations
Hit Papers
Peers
Comparison fields: 5 of 200
- Cancer Research 3.0k
- Genetics 4.8k
- Molecular Biology 9.6k
- Hepatology 1.0k
- Reproductive Medicine 1.0k
Countries citing papers authored by Feng Zhang
This map shows the geographic impact of Feng Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Zhang more than expected).
Fields of papers citing papers by Feng Zhang
This network shows the impact of papers produced by Feng Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Zhang. The network helps show where Feng Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Feng Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 8 | |
| 7 | 2024 | 2 | |
| 8 | 2023 | 14 | |
| 9 | 2023 | 11 | |
| 10 | 2023 | 9 | |
| 11 | 2023 | 3 | |
| 12 | 2021 | 9 | |
| 13 | 2021 | 38 | |
| 14 | 2020 | 5 | |
| 15 | Protective Effect of Pravastatin on Myocardial Ischemia Reperfusion Injury by Regulation of the miR-93/Nrf2/ARE Signal Pathway | 2020 | 1 |
| 16 | 2020 | 18 | |
| 17 | MicroRNA-379-5p/YBX1 Axis Regulates Cellular EMT to Suppress Migration and Invasion of Nasopharyngeal Carcinoma Cells | 2020 | 1 |
| 18 | A Review About Pembrolizumab in First-Line Treatment of Advanced NSCLC: Focus on KEYNOTE Studies | 2020 | 4 |
| 19 | 2018 | 21 | |
| 20 | 2007 | 85 |
About Feng Zhang
Feng Zhang is a scholar working on Cancer Research, Hepatology, Reproductive Medicine, Genetics and Molecular Biology, having authored 745 papers that have together received 20.1k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (52 papers), Genomic variations and chromosomal abnormalities (38 papers), Liver Disease Diagnosis and Treatment (35 papers), RNA modifications and cancer (34 papers), MicroRNA in disease regulation (33 papers), Chromosomal and Genetic Variations (31 papers), RNA Research and Splicing (31 papers) and Liver physiology and pathology (30 papers). The work is most often cited by research in Cancer Research (3.0k citations), Genetics (4.8k citations), Molecular Biology (9.6k citations), Hepatology (1.0k citations) and Reproductive Medicine (1.0k citations). Feng Zhang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include James R. Lupski, Wenli Gu, Shizhong Zheng, Matthew E. Hurles, Zili Zhang, Jiangjuan Shao, Jin Li, Claudia M.B. Carvalho, Xiaochun Yu and Anping Chen. Their work appears in journals such as PLoS ONE, Human Molecular Genetics, The American Journal of Human Genetics, Annals of Plastic Surgery and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.